Search Results - victor+solodushko

1 Results

Sort By:

Capless and Tailless Therapeutic Exogenous mRNA for Vaccine Development

Opportunity The approval and distribution of messenger RNA (mRNA) vaccines to successfully control the SARS-CoV-2 pandemic in 2021 exposed a major market for vaccine innovation and mRNA-based therapies. The mRNA used for treatment or vaccination is produced with a protecting 5’ cap and a 3’ poly-A tail at each end of the mRNA molecule....

Published: 6/12/2024 | Inventor(s): Brian Fouty, Victor Solodushko

Keywords(s):

Category(s): All Technologies, Antibody, Therapeutics, Vaccines, Gene Therapy and Delivery